Evolv Technologies Holdings Inc
For the period ended Dec 31, 2023. Filed Feb 29, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Feb 29, 2024
EVLV$4.44-6.7%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets as of December 31, 202 and
CONSOLIDATED BALANCE SHEETS
(In thousands, except share and per share amounts)
| December 31, | ||
|---|---|---|
| 2023 | 2022 | |
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $67,162 | $229,783 |
| Restricted cash | 275 | — |
| Marketable securities | 51,289 | — |
| Accounts receivable, net * | 22,611 | 31,920 |
| Inventory | 9,507 | 10,257 |
| Current portion of contract assets | 3,707 | 2,852 |
| Current portion of commission asset | 4,339 | 3,384 |
| Prepaid expenses and other current assets | 16,954 | 14,388 |
| Total current assets | 175,844 | 292,584 |
| Restricted cash, noncurrent | — | 275 |
| Contract assets, noncurrent | 451 | 1,386 |
| Commission asset, noncurrent | 7,107 | 5,655 |
| Property and equipment, net | 112,921 | 44,707 |
| Operating lease right-of-use assets | 1,195 | 1,673 |
| Other assets | 1,202 | 1,835 |
| Total assets | $298,720 | $348,115 |
| Liabilities and Stockholders’ Equity | ||
| Current liabilities: | ||
| Accounts payable | $17,400 | $18,194 |
| Accrued expenses and other current liabilities | 15,578 | 11,545 |
| Current portion of deferred revenue | 47,677 | 18,273 |
| Current portion of long-term debt | — | 10,000 |
| Current portion of operating lease liabilities | 1,391 | 1,114 |
| Total current liabilities | 82,046 | 59,126 |
| Deferred revenue, noncurrent | 23,813 | 17,695 |
| Long-term debt, noncurrent | — | 19,683 |
| Operating lease liabilities, noncurrent | — | 892 |
| Contingent earn-out liability | 29,119 | 14,218 |
| Contingently issuable common stock liability | 6,530 | 3,392 |
| Public warrant liability | 10,889 | 6,124 |
| Total liabilities | 152,397 | 121,130 |
| Commitments and contingencies (Note 19) | ||
| Stockholders’ equity: | ||
| Preferred stock, $0.0001 par value; 100,000,000 authorized at December 31, 2023 and December 31, 2022; no shares issued and outstanding at December 31, 2023 and December 31, 2022 | — | — |
| Common stock, $0.0001 par value; 1,100,000,000 shares authorized at December 31, 2023 and December 31, 2022, 151,310,080 and 145,204,974 shares issued and outstanding at December 31, 2023 and December 31, 2022, respectively | 15 | 15 |
| Additional paid-in capital | 444,825 | 419,190 |
| Accumulated other comprehensive loss | (53) | (10) |
| Accumulated deficit | (298,464) | (192,210) |
| Stockholders’ equity | 146,323 | 226,985 |
| Total liabilities and stockholders’ equity | $298,720 | $348,115 |
*Includes related party accounts receivable, net of $1.7 million and $14.6 million as of December 31, 2023 and December 31, 2022, respectively.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.